APA (7th ed.) Citation

HY, C., JC, L., PC, S., SB, Y., & CJ, L. (2026). Policy implications of mandatory systemic immunosuppressant trials prior to dupilumab for pediatric atopic dermatitis in Taiwan. Frontiers in pediatrics, 14, 1767209. https://doi.org/10.3389/fped.2026.1767209

Chicago Style (17th ed.) Citation

HY, Chen, Liao JC, Shih PC, Yong SB, and Li CJ. "Policy Implications of Mandatory Systemic Immunosuppressant Trials Prior to Dupilumab for Pediatric Atopic Dermatitis in Taiwan." Frontiers in Pediatrics 14 (2026): 1767209. https://doi.org/10.3389/fped.2026.1767209.

MLA (9th ed.) Citation

HY, Chen, et al. "Policy Implications of Mandatory Systemic Immunosuppressant Trials Prior to Dupilumab for Pediatric Atopic Dermatitis in Taiwan." Frontiers in Pediatrics, vol. 14, 2026, p. 1767209, https://doi.org/10.3389/fped.2026.1767209.